Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
At the index date in GLP-1 RA vs SGLT-2 inhibitor cohort, GLP-1 RA users were generally younger (median age 55 years [25-75 percentile: 45-65] vs 66 years [25-75 percentile: 57-74] more often female (59% vs 36%) and had a higher level of education compared with SGLT-2 inhibitor users (21% vs 15% were within ISCED level 6-8)
Initially created to manage type 2 diabetes, it has also proven effective in aiding weight loss for adults struggling with overweight people or those who are obese and managing at least one related health condition
C.Di BenedettoG.ScorranoL
Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease
Focus on metformin-a major cardiovascular medication
US$ 27.79
US$ 24.63
US$ 22.80
US$ 21.35
US$ 26.78
US$ 20.65
US$ 21.40
US$ 22.55
US$ 25.15
